A once-weekly insulin injection is an exciting development in diabetes care, but is it automatically better for everyone?

Awiqli is a new insulin injection that needs to be administered only once a week. Learn from a doctor about benefits, side ...

India now offers Awiqli, a new once-weekly basal insulin for diabetes patients. This drug reduces annual injections from 365 ...

The launch marks a major step in diabetes care, as patients who currently require one basal insulin injection every day may ...

Designed to reduce daily insulin injections to a single weekly dose, the long-acting insulin aims to improve treatment ...

India has become one of the first countries to introduce Awiqli, the world’s first once-weekly basal insulin for adults with ...

Danish pharma major Novo Nordisk on Thursday launched in India its once-weekly basal insulin injection, Awiqli indicated for ...

Novo Nordisk has launched Awiqli, the world's first once-weekly basal insulin, in India for adults with Type 1 and Type 2 diabetes. The shift from daily to weekly injections could ease treatment ...

India has become one of the first countries in the world to introduce Awiqli, the world's first once-a-week basal insulin ...

Danish pharma major Novo Nordisk on Thursday launched in India its once-weekly basal insulin injection, ‘Awiqli’ indicated for treatment of diabetes in adults. The company is introducing Awiqli in two ...

Launching its weekly insulin injectable 'Awiqli' in India, on Thursday, the Danish pharma major Novo Nordisk has brought some ...